Answers are grounded in this paper and cite their sources.
Intervertebral disc degeneration (IVDD) can contribute to low back pain, although imaging evidence of degeneration does not by itself identify a symptomatic spinal level. The cartilage endplate (CEP), situated between the intervertebral disc and the bony vertebral endplate, contributes to solute transport, load transfer, and maintenance of the nucleus pulposus tissue boundary. This review examines CEP physiology, structural and functional abnormalities, experimental mechanisms, and current clinical relevance. Human tissue and imaging studies have identified focal CEP abnormalities and associations with disc degeneration. Ex vivo , cell, and animal studies further suggest that altered nutrient and lactate exchange, abnormal loading, inflammation, oxidative stress, dysregulated autophagy, and ferroptosis may contribute to interactions between the CEP and adjacent disc tissues. These findings, however, do not establish the temporal sequence or clinical importance of these processes in patients. Conventional magnetic resonance imaging and computed tomography primarily depict the disc, bony endplate, and adjacent vertebral marrow; Modic changes are marrow abnormalities rather than direct measures of CEP degeneration. Ultrashort echo time and volumetric interpolated breath-hold examination imaging may improve assessment of CEP morphology, whereas dynamic contrast-enhanced and loaded imaging provide indirect information about the broader endplate region. Direct CEP imaging remains investigational because of limited standardization, histological validation, and longitudinal evidence. No CEP-specific imaging or molecular marker has been validated to independently localize a pain-generating level or guide treatment selection, and its prognostic value beyond established clinical and imaging measures remains incompletely established. Current evidence supports a testable model in which dysfunction of the CEP–nucleus pulposus interface may contribute to and amplify IVDD. Whether CEP abnormalities initiate degeneration, amplify an established process, or arise secondarily remains unresolved in humans.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: